FORE US BIO INC.

Profile

Company Names

FORE US BIO INC.

Addresses

3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA 19104

Phone Numbers

267-641-7575

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$132,489,567.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-04-30 
$70,410,173.00 
$109,619,395.00 
$39,209,222.00 
Equity 
1
2023-08-09 
$62,079,394.00 
$122,561,289.00 
$60,481,895.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KIM 
 
BLACKWELL 
DIRECTOR
MONTE ROSA THERAPEUTICS, INC.   |  FORE US BIO INC.   |  CHARM THERAPEUTICS INC.
MICHAEL 
 
BYRNES 
DIRECTOR, EXECUTIVE OFFICER
CERO THERAPEUTICS HOLDINGS, INC.   |  FORE US BIO INC.
MEENU 
 
CHHABRA KARSON 
DIRECTOR
FORE US BIO INC.
EREZ 
 
CHIMOVITS 
DIRECTOR
ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP   |  ADICET BIO, INC.   |  LOGICBIO THERAPEUTICS, INC.   |  ATOX BIO INC.   |  NOVUS THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  IMMPACT BIO USA INC.   |  GALECTO, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.
RAJEEV 
 
DADOO 
DIRECTOR
SYNOVEX CORP   |  ILLUMINOSS MEDICAL INC   |  AVHANA HEALTH, INC.   |  ADHERON THERAPEUTICS, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  PALLEON PHARMACEUTICALS INC.   |  DREN BIO, INC.   |  ARS PHARMACEUTICALS, INC.   |  SR ONE CAPITAL FUND II-B, LP   |  SR ONE CAPITAL FUND II-A, LP   |  SR ONE CAPITAL FUND III, LP   |  FORE US BIO INC.
ROBERTO 
 
DE PONTI 
DIRECTOR
ONCORESPONSE INC   |  FORE US BIO INC.   |  ONCORESPONSE, INC
MATTHEW 
 
FOY 
DIRECTOR
ATOX BIO INC.   |  SR ONE CAPITAL FUND II-B, LP   |  SR ONE CAPITAL FUND II-A, LP   |  FORE US BIO INC.
WILLIAM 
 
HINSHAW 
EXECUTIVE OFFICER, DIRECTOR
AXCELLA HEALTH INC.   |  FORE US BIO INC.
CHANDRA 
 
LEO 
DIRECTOR
GYNESONICS, INC   |  GALECTO, INC.   |  LONGBOARD PHARMACEUTICALS, INC.   |  DREN BIO, INC.   |  FORE US BIO INC.
GIOVANNI 
 
MARIGGI 
DIRECTOR
CUREVO, INC.   |  FORE US BIO INC.   |  ILLEXCOR THERAPEUTICS, INC.
MATTHEW 
 
ROS 
EXECUTIVE OFFICER, DIRECTOR
UNUM THERAPEUTICS INC.   |  FORE US BIO INC.
JEFF 
 
SACHER 
EXECUTIVE OFFICER
FORE US BIO INC.
MICHAL 
 
SILVERBERG 
DIRECTOR
GALERA THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ADICET BIO, INC.   |  IMMPACT BIO USA INC.   |  REDONA THERAPEUTICS, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.   |  AVERNA THERAPEUTICS INC.
DIETER 
 
WEINAND 
DIRECTOR
HEALTHPRIZE TECHNOLOGIES, LLC   |  ZIELBIO, INC.   |  INSPIRNA, INC.   |  FORE US BIO INC.   |  COYA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-30 
2025-05-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-30 
2023-08-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#